160 related articles for article (PubMed ID: 29381754)
1. Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection.
Benmassaoud A; Ghali P; Cox J; Wong P; Szabo J; Deschenes M; Osikowicz M; Lebouche B; Klein MB; Sebastiani G
PLoS One; 2018; 13(1):e0191985. PubMed ID: 29381754
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients.
Vuille-Lessard É; Lebouché B; Lennox L; Routy JP; Costiniuk CT; Pexos C; Giannakis A; Szabo J; Klein MB; Sebastiani G
AIDS; 2016 Nov; 30(17):2635-2643. PubMed ID: 27603289
[TBL] [Abstract][Full Text] [Related]
3. Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients.
Sebastiani G; Saeed S; Lebouche B; de Pokomandy A; Szabo J; Haraoui LP; Routy JP; Wong P; Deschenes M; Ghali P; Klein M;
AIDS; 2020 Feb; 34(2):237-244. PubMed ID: 31651429
[TBL] [Abstract][Full Text] [Related]
4. A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease.
Yilmaz Y; Eren F
Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1292-5. PubMed ID: 25171027
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study.
Alhinai A; Qayyum-Khan A; Zhang X; Samaha P; Metrakos P; Deschenes M; Wong P; Ghali P; Chen TY; Sebastiani G
World J Hepatol; 2021 Dec; 13(12):2179-2191. PubMed ID: 35070018
[TBL] [Abstract][Full Text] [Related]
6. Ability of Cytokeratin-18 Fragments and FIB-4 Index to Diagnose Overall and Mild Fibrosis Nonalcoholic Steatohepatitis in Japanese Nonalcoholic Fatty Liver Disease Patients.
Kobayashi N; Kumada T; Toyoda H; Tada T; Ito T; Kage M; Okanoue T; Kudo M
Dig Dis; 2017; 35(6):521-530. PubMed ID: 29040984
[TBL] [Abstract][Full Text] [Related]
7. [Value of a two-step approach with cytokeratin-18 and controlled attenuation parameter in noninvasive differential diagnosis of nonalcoholic steatohepatitis].
Shen F; Zheng RD; Mi YQ; Shi JP; Wang XY; Hu XQ; Pan Q; Xu LM; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):429-34. PubMed ID: 27465946
[TBL] [Abstract][Full Text] [Related]
8. Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease.
Lee HW; Park SY; Kim SU; Jang JY; Park H; Kim JK; Lee CK; Chon YE; Han KH
PLoS One; 2016; 11(6):e0157358. PubMed ID: 27284700
[TBL] [Abstract][Full Text] [Related]
9. Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography.
Saroli Palumbo C; Restellini S; Chao CY; Aruljothy A; Lemieux C; Wild G; Afif W; Lakatos PL; Bitton A; Cocciolillo S; Ghali P; Bessissow T; Sebastiani G
Inflamm Bowel Dis; 2019 Jan; 25(1):124-133. PubMed ID: 29889226
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome.
Shengir M; Krishnamurthy S; Ghali P; Deschenes M; Wong P; Chen T; Sebastiani G
World J Gastroenterol; 2020 Nov; 26(44):7046-7060. PubMed ID: 33311949
[TBL] [Abstract][Full Text] [Related]
11. Transient Elastography in HIV Infected Patients with Liver Steatosis Identifies a High-Risk Group for Non-Alcoholic Steatohepatitis.
Pezzini MF; Cheinquer H; de Araujo A; Schmidt-Cerski CT; Sprinz E; Herz-Wolff F; Poeta J
Curr HIV Res; 2021; 19(4):311-316. PubMed ID: 33632105
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients.
Merchante N; Rivero A; de Los Santos-Gil I; Merino D; Márquez M; López-Ruz MA; Rodríguez-Baño J; Del Valle J; Camacho A; Sanz-Sanz J; Macías J; Pérez-Camacho I; Gómez-Mateos J; Moro A; Pineda JA
Gut; 2009 Dec; 58(12):1654-60. PubMed ID: 19625279
[TBL] [Abstract][Full Text] [Related]
13. Cost-utility analysis of nonalcoholic steatohepatitis screening.
Zhang E; Wartelle-Bladou C; Lepanto L; Lachaine J; Cloutier G; Tang A
Eur Radiol; 2015 Nov; 25(11):3282-94. PubMed ID: 25994191
[TBL] [Abstract][Full Text] [Related]
14. Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis.
Macias J; Parra-Membrives P; Sosa-Moreno F; Rincon P; Martinez-Baena D; Fernandez-Fuertes M; Lorente-Herce JM; Martinez RC; Jimenez-Riera G; Corma-Gomez A; Gonzalez-Serna A; Pineda JA; Real LM
Sci Rep; 2022 Dec; 12(1):21897. PubMed ID: 36536019
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of liver steatosis and fibrosis in unselected patients with HIV mono-infection.
Lombardi R; Sambatakou H; Mariolis I; Cokkinos D; Papatheodoridis GV; Tsochatzis EA
Dig Liver Dis; 2016 Dec; 48(12):1471-1477. PubMed ID: 27623186
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
Liu D; Shen Y; Zhang R; Xun J; Wang J; Liu L; Steinhart C; Chen J; Lu H
J Gastroenterol Hepatol; 2021 Jun; 36(6):1670-1678. PubMed ID: 33140878
[TBL] [Abstract][Full Text] [Related]
17. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
Purnomo HD; Mundhofir FE; Kasno ; Sudijanto E; Darmono ; Daldiyono ; Djokomoeljanto R; Faradz SM
Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease.
Castera L
Semin Liver Dis; 2015 Aug; 35(3):291-303. PubMed ID: 26378645
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population.
Sepulveda-Villegas M; Roman S; Rivera-Iñiguez I; Ojeda-Granados C; Gonzalez-Aldaco K; Torres-Reyes LA; Jose-Abrego A; Panduro A
PLoS One; 2019; 14(1):e0208926. PubMed ID: 30608932
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.
Morse CG; McLaughlin M; Matthews L; Proschan M; Thomas F; Gharib AM; Abu-Asab M; Orenstein A; Engle RE; Hu X; Lempicki R; Hadigan C; Kleiner DE; Heller T; Kovacs JA
Clin Infect Dis; 2015 May; 60(10):1569-78. PubMed ID: 25681381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
